Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Biote Corp has a consensus price target of $9.07 based on the ratings of 8 analysts. The high is $12 issued by Craig-Hallum on December 16, 2024. The low is $6.55 issued by Jefferies on February 1, 2024. The 3 most-recent analyst ratings were released by Craig-Hallum, Roth MKM, and B. Riley Securities on December 16, 2024, March 13, 2024, and February 20, 2024, respectively. With an average price target of $10 between Craig-Hallum, Roth MKM, and B. Riley Securities, there's an implied 63.92% upside for Biote Corp from these most-recent analyst ratings.
1calculated from analyst ratings
The latest price target for Biote (NASDAQ:BTMD) was reported by Craig-Hallum on December 16, 2024. The analyst firm set a price target for $12.00 expecting BTMD to rise to within 12 months (a possible 96.71% upside). 6 analyst firms have reported ratings in the last year.
The latest analyst rating for Biote (NASDAQ:BTMD) was provided by Craig-Hallum, and Biote initiated their buy rating.
There is no last upgrade for Biote
There is no last downgrade for Biote.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Biote, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Biote was filed on December 16, 2024 so you should expect the next rating to be made available sometime around December 16, 2025.
While ratings are subjective and will change, the latest Biote (BTMD) rating was a initiated with a price target of $0.00 to $12.00. The current price Biote (BTMD) is trading at is $6.10, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.